TP53 and stroke disorder: Therefore, it can be concluded that 1,25-D3 promoted VEGF and TGF-β mRNA expression and reduced the expression of apoptotic factor P53 mRNA by activating VDR, thereby promoting angiogenesis after stroke, reducing apoptosis caused by mitochondrial metabolic disorders, and alleviating brain injury.